NEA, 5AM back a $50M play to steer gene ther­a­pies to the clin­ic at Ak­ou­os — the lat­est start­up in hear­ing

Hear­ing is get­ting to be a trendy R&D top­ic in biotech.

Eight months af­ter putting to­geth­er a $7.5 mil­lion seed round and lin­ing up AAV …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.